Our Inspiration
- Living With Rare Diseases
- Real Stories
  - aHUS
  - gMG
  - HPP
  - LAL-D
  - NMOSD
  - PNH
- Support Services
Albie, one of our guiding stars

When Albie was born, his mom, Charlotte, said that he was “absolutely fine. Everything was fine for about two weeks.”
Our Medicines
- Conditions We Treat
  - aHUS
  - gMG
  - HPP
  - LAL-D
  - NF1 PN
  - NMOSD
  - PNH
- Medicines
- Expanded Access Programs
Our medicines help people like Donnan

As a father of two young children, Donnan recalls being afraid of what the future would hold prior to his diagnosis.
Our Research
We innovate for Ruthie

Married with a newborn son, Ruthie was scared to learn that PNH was a life-threatening illness that at the time had no approved treatment.
Our Commitment
We give back for families like Evie's

At only three months old, Evie's parents were told that her case was severe and that there were no approved or effective treatment options.
Our Company
Roberta is our inspiration

Despite having a constant struggle with symptoms, Roberta revisited her dreams and put herself through nursing school.
Your Career
- Career Opportunities
- Working Here
  - Benefits
  - Culture
Make a difference for families like Tristan's

Tristan's parents experienced a whirlwind of emotions and fear after learning their 5-year-old son had such a rare and serious disease.

LEADERSHIP

Lukasz Jarzyna

VP, Global Access and Pricing

Lukasz Jarzyna is Vice President, Head of Global Value, Access, and Pricing (GVAP) of Alexion, AstraZeneca Rare Disease.

Connect

About Lukasz

Lukasz leads the Global Value, Access, and Pricing (GVAP) team, working on global pricing and reimbursement strategies for Alexion’s products across all stages of development. Lukasz joined Alexion in 2015 in the International organization in Zurich. He completed his management studies at Lazarski University in Warsaw, Poland. Lukasz started his career as a Tax and Management Consultant in Austria, and prior to Alexion worked at Amgen and Pfizer in country and regional roles. In 2021, Lukasz was recognized as an Emerging Pharma Leader by Pharmaceutical Executive.

Tristan, diagnosed with LAL-D at 5 years old

He’s a typical kid who just wants to run and play; and he really doesn’t let this disease hold him back.”

HOLLY, TRISTAN’S MOM LIVING WITH LAL-D

HEAR HIS STORY

Lukasz Jarzyna

VP, Global Access and Pricing

About Lukasz

You are now leaving www.alexion.com, a website provided by Alexion Pharmaceuticals, Inc. This link will take you to a different site to which this Privacy Policy does not apply.

You are now leaving the alexion.com UK webpage for the global alexion.com website. The content on the global site is intended for a U.S. audience only